Watson 4Q profit climbs on generic Lipitor sales
PARSIPPANY, N.J. (AP) — Generic drugmaker Watson Pharmaceuticals Inc. said Tuesday its profit surged in the fourth quarter as it began selling a low-cost version of the cholesterol drug Lipitor.
Watson said its profit grew to $94.8 million, or 75 cents per share, from $18.3 million, or 15 cents per share, one year earlier. Revenue jumped 62 percent to $1.54 billion from $952.7 million, as sales of generic drugs ...
You have selected to view an article that is older than 60 days. There are several ways to unlock access to NewsOK historical content.
Please sign in. (You might already have access)
If you are a print subscriber to The Oklahoman, activate your Digital Pass for free access.
Purchase any of The Oklahoman's digital products (digital replica, archives, iPad and smartphone apps), and access to historical NewsOK content is free.
Please sign in. (You might already have access)
If you are a print subscriber to The Oklahoman, activate your Digital Pass for free access.
Purchase any of The Oklahoman's digital products (digital replica, archives, iPad and smartphone apps), and access to historical NewsOK content is free.
